Pancreaticoduodenectomy with radical lymphadenectomy is not contraindicated for patients with established chronic liver disease and portal hypertension

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 1, 2008, Pages 82-85

  Sethi, Harsheet ^a   Srinivasan, Parthi ^a   Marangoni, Gabriele ^a   Prachalias, Andreas ^a   Rela, Mohamed ^a   Heaton, Nigel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic liver disease; Cirrhosis; Pancreaticoduodenectomy; Portal hypertension; Whipple's

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; DIURETIC AGENT; FRESH FROZEN PLASMA; PROPRANOLOL;

ADJUVANT THERAPY; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; BLEEDING; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DECOMPRESSION; DISEASE FREE SURVIVAL; FATALITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FAILURE; LYMPHADENECTOMY; MALE; NONALCOHOLIC FATTY LIVER; PANCREAS CANCER; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; PORTAL HYPERTENSION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCORING SYSTEM; SURGICAL TECHNIQUE;

ABDOMINAL NEOPLASMS; ADULT; AGED; ASCITES; FEMALE; HEPATITIS, CHRONIC; HUMANS; HYPERTENSION, PORTAL; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; PATIENT SELECTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 39049113803     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cobb WS, Heniford BT, Burns JM, Carbonell AM, Matthews BD, Kercher KW. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc 2005;19:418-423.
2. Doberneck RC, Sterling WA Jr, Allison DC. Morbidity and mortality after operation in nonbleeding cirrhotic patients. Am J Surg 1983;146:306-309.
3. Brennan MF, Kinsella TJ, Casper ES. Cancer of the pancreas. DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. Philadelphia, PA: JB Lippincott Co; 1993:849-882.
4. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996;223:506-511; discussion 511-512.
5. Gil A, Martínez-Regueira F, Hernández-Lizoain JL, Pardo F, Olea JM, Bastarrika G, et al. The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension. Eur J Surg Oncol 2004;30:46-52.
6. Izbicki JR, Yekebas EF, Strate T, Eisenberger CF, Hosch SB, Steffani K, et al. Extrahepatic portal hypertension in chronic pancreatitis: an old problem revisited. Ann Surg 2002;236:82-89.
7. Belli G, Fantini C, Ciciliano F, D'Agostino A, Barberio M. Pancreaticoduodenectomy in portal hypertension: use of the Ligasure. J Hepatobiliary Pancreat Surg 2003;10: 215-217.
8. Azoulay D, Buabse F, Damiano I, Smail A, Ichai P, Dannaoui M, et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 2001;193:46-51.
9. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 2005;242:244-251.
10. Wong R, Rappaport W, Witte C, Hunter G, Jaffe P, Hall K, et al. Risk of nonshunt abdominal operation in the patient with cirrhosis. J Am Coll Surg 1994;179:412-416.
11. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 1997;122:730-735.
12. Schwartz SI. Biliary tract surgery and cirrhosis: a critical combination. Surgery 1981;90:577-583.
13. Carbó J, García-Samaniego J, Castellano G, Iñiguez A, Solís-Herruzo JA. Liver cirrhosis and mortality by abdominal surgery. A study of risk factors. Rev Esp Enferm Dig 1998;90:105-112.
14. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999; 90:42-53.
15. Rice HE, O'Keefe GE, Helton WS, Johansen K. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg 1997;132:880-884; discussion 884-885.
16. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
17. Urbach DR, Bell CM, Austin PC. Differences in operative mortality between high- and low-volume hospitals in Ontario for 5 major surgical procedures: estimating the number of lives potentially saved through regionalization. CMAJ 2003;168:1409-1414.
18. Launois B, Huguier M. Evidence based surgery of cancer of head of pancreas. Bull Acad Natl Med 2004;188:743-752; discussion 753-754.
19. Glasgow RE, Mulvihill SJ. Hospital volume influences outcome in patients undergoing pancreatic resection for cancer. West J Med 1996;165:294-300.
20. Sirinek KR, Burk RR, Brown M, Levine BA. Improving survival in patients with cirrhosis undergoing major abdominal operations. Arch Surg 1987;122:271-273.
21. Vinet E, Perreault P, Bouchard L, Bernard D, Wassef R, Richard C, et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol 2006;20:401-414.
22. Ryu KW, Lee JH, Kim YW, Park JW, Bae JM. Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg 2005;29:653-656.
23. Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N, et al. Distant lymph node metastasis of early gastric cancer. Surg Today 1997;27:600-605.
24. Danese C, Howard JM, Bower R. Regeneration of lymphatic vessels: a radiographic study. Ann Surg 1962; 156:61-67.